Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
2004 1
2007 2
2009 1
2010 2
2011 3
2015 1
2016 2
2018 1
2019 1
2020 4
2021 6
2022 5
2023 5
2024 13
2025 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: OVHIPEC-2, a phase III randomized clinical trial.
Koole S, van Stein R, Sikorska K, Barton D, Perrin L, Brennan D, Zivanovic O, Mosgaard BJ, Fagotti A, Colombo PE, Sonke G, Driel WJV; OVHIPEC-2 Steering Committee and the Dutch OVHIPEC group. Koole S, et al. Int J Gynecol Cancer. 2020 Jun;30(6):888-892. doi: 10.1136/ijgc-2020-001231. Epub 2020 Mar 23. Int J Gynecol Cancer. 2020. PMID: 32205449 Free PMC article.
Vvax001, a Therapeutic Vaccine, for Patients with HPV16-Positive High-grade Cervical Intraepithelial Neoplasia: A Phase II Trial.
Eerkens AL, Esajas MD, Brummel K, Vledder A, van Rooij N, Plat A, Avalos Haro SB, Paijens ST, Slagter-Menkema L, Schuuring E, Werner N, Kosterink JGW, Kroesen BJ, Wilschut JC, Daemen T, Bart J, Nijman HW, de Bruyn M, Yigit R. Eerkens AL, et al. Among authors: yigit r. Clin Cancer Res. 2025 Mar 17;31(6):1016-1026. doi: 10.1158/1078-0432.CCR-24-1662. Clin Cancer Res. 2025. PMID: 39849926 Clinical Trial.
Neoadjuvant immune checkpoint blockade in women with mismatch repair deficient endometrial cancer: a phase I study.
Eerkens AL, Brummel K, Vledder A, Paijens ST, Requesens M, Loiero D, van Rooij N, Plat A, Haan FJ, Klok P, Yigit R, Roelofsen T, de Lange NM, Klomp R, Church D, Ter Elst A, Wardenaar R, Spierings D, Foijer F, Koelzer VH, Bosse T, Bart J, Jalving M, Reyners AKL, de Bruyn M, Nijman HW. Eerkens AL, et al. Among authors: yigit r. Nat Commun. 2024 Sep 3;15(1):7695. doi: 10.1038/s41467-024-52098-8. Nat Commun. 2024. PMID: 39227583 Free PMC article. Clinical Trial.
B cells critical for outcome in high grade serous ovarian carcinoma.
Vledder A, Paijens ST, Loiero D, Maagdenberg A, Duiker EW, Bart J, Hendriks AM, Jalving M, Werner N, van Rooij N, Plat A, Wisman GBA, Yigit R, Roelofsen T, Kruse AJ, de Lange NM, Koelzer VH, de Bruyn M, Nijman HW. Vledder A, et al. Among authors: yigit r. Int J Cancer. 2024 Dec 15;155(12):2265-2276. doi: 10.1002/ijc.35149. Epub 2024 Aug 22. Int J Cancer. 2024. PMID: 39175107
Predicting homozygous M694V genotype in paediatric FMF: multicentre analysis and scoring system proposal.
Tunce E, Atamyıldız Uçar S, Polat MC, Altuğ Gücenmez Ö, Çakan M, Bozkaya Yücel B, Arslanoğlu Aydın E, Doğan Kuzuca T, Kılıç Könte E, Demirhan S, Küçük E, Arık SD, Vatansever G, Özkaya O, Tekcan D, Nalçacıoğlu H, Tanatar A, Karakaş HD, Açarı C, Doğantan Ş, Şener S, Kışla Ekinci RM, Garipçin P, Ercan Emreol H, Kurt T, Adıgüzel Dündar H, Girgeç A, Arif Tutuş A, Köker O, Cevizbaş S, Kutlar Tanıdır M, Tığrak SN, Sezer M, Kazanasmaz H, Öksel B, Taşkın RB, Gümüşsoy Ay E, Coşkuner T, Özomay Baykal G, Yiğit RE, Türkmen Ş, Ulu K, Taşkın SN, Otar Yener G, Demir F, Kilic SS, Gürgöze MK, Aksu G, Sönmez HE, Türkuçar S, Kalyoncu M, Bakkaloğlu S, Özkayın N, Kasap Demir B, Ünsal E, Yüksel S, Balat A, Bilginer Y, Paç Kısaarslan A, Dönmez O, Aktay Ayaz N, Öztürk K, Demir S, Bağlan E, Çelikel E, Kasapçopur Ö, Özen S, Sözeri B. Tunce E, et al. Among authors: yigit re. Rheumatology (Oxford). 2025 Aug 1;64(8):4816-4824. doi: 10.1093/rheumatology/keaf221. Rheumatology (Oxford). 2025. PMID: 40257440
Cancer risks for other sites in addition to breast in CHEK2 c.1100delC families.
Schreurs MAC, Schmidt MK, Hollestelle A, Schaapveld M, van Asperen CJ, Ausems MGEM, van de Beek I, Broekema MF, Margriet Collée J, van der Hout AH, van Kaam KJAF, Komdeur FL, Mensenkamp AR, Adank MA, Hooning MJ; Hereditary Breast and Ovarian Cancer Research Group Netherlands. Schreurs MAC, et al. Genet Med. 2024 Sep;26(9):101171. doi: 10.1016/j.gim.2024.101171. Epub 2024 May 31. Genet Med. 2024. PMID: 38828701 Free article.
Long-term outcome of high-grade serous carcinoma established in risk-reducing salpingo-oophorectomy specimens in asymptomatic BRCA1/2 germline pathogenic variant carriers.
Stroot IAS, Bart J, Hollema H, Jalving M, Wagner MM, Yigit R, van Doorn HC, de Hullu JA, Gaarenstroom KN, van Beurden M, van Lonkhuijzen LRCW, Slangen BFM, Zweemer RP, Gómez García EB, Ausems MGEM, Boere IA, van Hest LP, Duijkers FAM, van Asperen CJ, Schmidt MK, Wevers MR, Ruijs MWG, Devilee P, Collée JM, Hebon Investigators, de Bock GH, Mourits MJE. Stroot IAS, et al. Among authors: yigit r. Gynecol Oncol. 2024 Aug;187:198-203. doi: 10.1016/j.ygyno.2024.05.024. Epub 2024 May 24. Gynecol Oncol. 2024. PMID: 38795508 Free article.
An overview of Clinical Quality Registries (CQRs) on gynecological oncology worldwide.
Baldewpersad Tewarie N, van Driel WJ, van Ham MAPC, Wouters MW, Rome RM, Høgdall CK, Pagano E, Hogberg T, Kruitwagen R; participants of the - Dutch Gynecological Oncology Group. Baldewpersad Tewarie N, et al. Eur J Surg Oncol. 2022 Oct;48(10):2094-2103. doi: 10.1016/j.ejso.2022.06.020. Epub 2022 Jun 23. Eur J Surg Oncol. 2022. PMID: 35931589 Free article. Review.
High-grade serous carcinoma occurring after risk-reducing salpingo-oophorectomy in BRCA1/2 germline pathogenic variant carriers.
Stroot IAS, Bart J, Hollema H, Wagner MM, Yigit R, van Doorn HC, de Hullu JA, Gaarenstroom KN, van Beurden M, van Lonkhuijzen LRCW, Slangen BFM, Zweemer RP, Gómez Garcia EB, Ausems MGEM, Komdeur FL, van Asperen CJ, Adank MA, Wevers MR, Hooning MJ; HEBON Investigators; Mourits MJE, de Bock GH. Stroot IAS, et al. Among authors: yigit r. J Natl Cancer Inst. 2025 Apr 1;117(4):719-727. doi: 10.1093/jnci/djae300. J Natl Cancer Inst. 2025. PMID: 39579093
53 results